Published in Biol Blood Marrow Transplant on December 19, 2010
Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation. Exp Mol Pathol (2013) 0.94
Rapid thymic reconstitution following bone marrow transplantation in neonatal mice is VEGF-dependent. Biol Blood Marrow Transplant (2012) 0.78
Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology. Blood (2014) 0.77
Modeling promising nonmyeloablative conditioning regimens in nonhuman primates. Hum Gene Ther (2014) 0.77
NOD Scid Gamma Mice Are Permissive to Allogeneic HSC Transplantation without Prior Conditioning. Int J Mol Sci (2016) 0.76
Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma. Int J Cancer Res (2016) 0.75
Engraftment and bone mass are enhanced by PTHrP 1-34 in ectopically transplanted vertebrae (vossicle model) and can be non-invasively monitored with bioluminescence and fluorescence imaging. Transgenic Res (2015) 0.75
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol (2005) 9.76
How do stem cells find their way home? Blood (2005) 5.13
Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med (1989) 3.34
The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) (2005) 3.24
Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med (2003) 2.31
Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature (1986) 2.25
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16
The total marrow mass of the mouse: a simplified method of measurement. Am J Hematol (1984) 2.05
Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol (1996) 1.82
Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood (2003) 1.79
Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarly in irradiated and nonirradiated sites. Blood (2003) 1.64
A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood (2002) 1.64
SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood (2002) 1.59
Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood (2001) 1.54
Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood (2002) 1.45
Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood (1994) 1.44
Bone marrow cell trafficking following intravenous administration. Br J Haematol (1999) 1.43
Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol (2000) 1.43
Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med (1997) 1.27
Distribution of marrow repopulating cells between bone marrow and spleen early after transplantation. Blood (2003) 1.09
Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol (2004) 1.02
Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice. Exp Hematol (2005) 0.84
Degeneration of stroma reduces retention of homed cells in bone marrow of lethally irradiated mice. Stem Cells Dev (2004) 0.84
Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review. Am J Clin Oncol (2009) 0.81
Stem-cell biology and cancer therapy: the more things change... J Clin Oncol (2008) 0.80
Non-myeloablative allogeneic hematopoietic stem cell transplantation. Semin Oncol Nurs (2009) 0.80
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol (2010) 6.55
A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells (2007) 1.87
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood (2012) 1.85
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res (2005) 1.84
Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood (2003) 1.79
Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2010) 1.74
Perivascular support of human hematopoietic stem/progenitor cells. Blood (2013) 1.67
Idiopathic and diabetic skeletal muscle necrosis: evaluation by magnetic resonance imaging. Skeletal Radiol (2005) 1.62
Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl. Blood (2008) 1.51
Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans. Blood (2004) 1.32
Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology (2007) 1.30
Immune-cell lineage commitment: translation from mice to humans. Immunity (2007) 1.29
Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology (2008) 1.27
Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Mol Ther (2005) 1.25
Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin. Nat Immunol (2012) 1.22
Inferring relative numbers of human leucocyte genome replications. Br J Haematol (2008) 1.22
Identification of the critical extracellular matrix proteins that promote human embryonic stem cell assembly. Stem Cells Dev (2009) 1.15
Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon. Exp Hematol (2006) 1.13
Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors. Blood (2007) 1.12
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood (2013) 1.08
Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system. Hum Gene Ther (2009) 1.08
TG-69: radiographic film for megavoltage beam dosimetry. Med Phys (2007) 1.06
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatr Blood Cancer (2010) 1.05
VEGF-mediated cross-talk within the neonatal murine thymus. Blood (2008) 0.97
Ikaros isoform x is selectively expressed in myeloid differentiation. J Immunol (2003) 0.96
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. PLoS One (2012) 0.95
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report. Blood (2006) 0.95
Bone marrow fails to differentiate into liver epithelium during murine development and regeneration. Hepatology (2007) 0.94
Lysophosphatidic acid mediates myeloid differentiation within the human bone marrow microenvironment. PLoS One (2013) 0.89
The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants. Biol Blood Marrow Transplant (2007) 0.88
Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis. Am J Clin Oncol (2014) 0.88
Critical differences in hematopoiesis and lymphoid development between humans and mice. J Clin Immunol (2012) 0.87
Clinical and genetic heterogeneity in Omenn syndrome and severe combined immune deficiency. Pediatr Transplant (2008) 0.87
Human hematopoietic lineage commitment. Immunol Rev (2002) 0.87
SCL expression at critical points in human hematopoietic lineage commitment. Stem Cells (2005) 0.87
Formation of pancreatic duct epithelium from bone marrow during neonatal development. Stem Cells (2006) 0.86
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol Ther (2002) 0.86
The unpredictable stem cell. Nat Immunol (2006) 0.86
Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation. J Pediatr Hematol Oncol (2004) 0.85
Engineering the human thymic microenvironment to support thymopoiesis in vivo. Stem Cells (2014) 0.84
Successful hematopoietic stem cell transplantation for Niemann-Pick disease type B. Pediatrics (2005) 0.84
Dysregulated gene expression during hematopoietic differentiation from human embryonic stem cells. Mol Ther (2010) 0.82
Fluorescent immunohistochemistry and in situ hybridization analysis of pancreas. Methods Mol Biol (2009) 0.82
The challenges and promises of blood engineered from human pluripotent stem cells. Adv Drug Deliv Rev (2011) 0.81
Fluorescent immunohistochemistry and in situ hybridization analysis of mouse pancreas using low-power antigen-retrieval technique. J Histochem Cytochem (2006) 0.81
Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow. Exp Hematol (2011) 0.80
Novel pathways to erythropoiesis induced by dimerization of intracellular C-Mpl in human hematopoietic progenitors. Stem Cells (2012) 0.80
Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys (2013) 0.80
Isolation of CD133+ liver stem cells for clonal expansion. J Vis Exp (2011) 0.79
Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signaling. Stem Cells (2014) 0.79
Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells. Leuk Res (2006) 0.79
Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis. J Clin Immunol (2011) 0.78
Rapid thymic reconstitution following bone marrow transplantation in neonatal mice is VEGF-dependent. Biol Blood Marrow Transplant (2012) 0.78
Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatr Blood Cancer (2014) 0.76
Optimal treatment for intracranial germinoma: can we lower, radiation dose without chemotherapy? In regard to Yen S-H et al. (Int J Radiat Oncol Biol Phys Epub October 27, 2009). Int J Radiat Oncol Biol Phys (2010) 0.75
Pre- and post-natal treatment of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2009) 0.75
Regulated expansion of human pancreatic beta-cells. Mol Ther (2010) 0.75
In regard to Urie et al.: current calibration treatment, and treatment planning techniques among institutions participating in the Children's Oncology Group. IJROBP 2003;55:245-260. Int J Radiat Oncol Biol Phys (2003) 0.75
Uncertainty plagues US stem cell research. Pediatr Res (2010) 0.75
Second hematopoietic stem cell transplantation in pediatric patients: overall survival and long-term follow-up. Biol Blood Marrow Transplant (2002) 0.75
AAPM Medical Physics Practice Guideline 2.a: Commissioning and quality assurance of X-ray-based image-guided radiotherapy systems. J Appl Clin Med Phys (2014) 0.75
A retrospective analysis of recurrent intracranial ependymoma. Pediatr Blood Cancer (2014) 0.75